Atlas Trials

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Clinical trial NCT01580293 · COMPLETED

Trial details

NCT number
NCT01580293
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hemophilia A
Start date
2012-04-23
Primary completion
2014-06-13
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.